126 related articles for article (PubMed ID: 38385340)
41. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration.
Liu Y; Keefe K; Tang X; Lin S; Smith GM
PLoS One; 2014; 9(2):e87447. PubMed ID: 24498323
[TBL] [Abstract][Full Text] [Related]
42. Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice.
Levicoff EA; Kim JS; Sobajima S; Wallach CJ; Larson JW; Robbins PD; Xiao X; Juan L; Vadala G; Gilbertson LG; Kang JD
Spine (Phila Pa 1976); 2008 Jun; 33(14):1509-16; discussion 1517. PubMed ID: 18520636
[TBL] [Abstract][Full Text] [Related]
43. Absence of functional deficits in rats following systemic administration of an AAV9 vector despite moderate peripheral nerve and dorsal root ganglia findings: A clinically silent peripheral neuropathy.
Tyszkiewicz C; Hwang SK; DaSilva JK; Kovi RC; Fader KA; Sirivelu MP; Liu J; Somps C; Cook J; Liu CN; Wang H
Neurotoxicology; 2024 Mar; 101():46-53. PubMed ID: 38316190
[TBL] [Abstract][Full Text] [Related]
44. Scientific and Regulatory Policy Committee Points to Consider: Sampling, Processing, Evaluation, Interpretation, and Reporting of Test Article-Related Ganglion Pathology for Nonclinical Toxicity Studies.
Bennet BM; Pardo ID; Assaf BT; Buza E; Cramer S; Crawford LK; Engelhardt JA; Grubor B; Morrison JP; Osborne TS; Sharma AK; Bolon B
Toxicol Pathol; 2023 Jun; 51(4):176-204. PubMed ID: 37489508
[TBL] [Abstract][Full Text] [Related]
45. A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons.
Fagoe ND; Eggers R; Verhaagen J; Mason MR
Gene Ther; 2014 Mar; 21(3):242-52. PubMed ID: 24285216
[TBL] [Abstract][Full Text] [Related]
46. Neurofilament light chain and dorsal root ganglia injury after adeno-associated virus 9 gene therapy in nonhuman primates.
Johnson EW; Sutherland JJ; Meseck E; McElroy C; Chand DH; Tukov FF; Hudry E; Penraat K
Mol Ther Methods Clin Dev; 2023 Mar; 28():208-219. PubMed ID: 36700120
[TBL] [Abstract][Full Text] [Related]
47. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
Eslami MH; Gangadharan SP; Sui X; Rhynhart KK; Snyder RO; Conte MS
J Vasc Surg; 2000 Jun; 31(6):1149-59. PubMed ID: 10842152
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the efficiencies of intrathecal and intraganglionic injections in mouse dorsal root ganglion.
Aydin MŞ; Yiğit EN
Turk J Med Sci; 2023; 53(5):1358-1366. PubMed ID: 38813001
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
[TBL] [Abstract][Full Text] [Related]
50. The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits.
Lattermann C; Oxner WM; Xiao X; Li J; Gilbertson LG; Robbins PD; Kang JD
Spine (Phila Pa 1976); 2005 Mar; 30(5):497-504. PubMed ID: 15738780
[TBL] [Abstract][Full Text] [Related]
51. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
52. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
53. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
54. Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves.
Wang X; Wang C; Zeng J; Xu X; Hwang PY; Yee WC; Ng YK; Wang S
Mol Ther; 2005 Aug; 12(2):314-20. PubMed ID: 15925545
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex viral and amplicon vector-mediated gene transfer into glia and neurons in organotypic spinal cord and dorsal root ganglion cultures.
Marsh DR; Dekaban GA; Tan W; Strathdee CA; Weaver LC
Mol Ther; 2000 May; 1(5 Pt 1):464-78. PubMed ID: 10933968
[TBL] [Abstract][Full Text] [Related]
56. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
[TBL] [Abstract][Full Text] [Related]
57. AAV-encoded Ca
Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
[TBL] [Abstract][Full Text] [Related]
58. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.
Goins WF; Lee KA; Cavalcoli JD; O'Malley ME; DeKosky ST; Fink DJ; Glorioso JC
J Virol; 1999 Jan; 73(1):519-32. PubMed ID: 9847358
[TBL] [Abstract][Full Text] [Related]
59. Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus-Related Toxicity.
Khabou H; Cordeau C; Pacot L; Fisson S; Dalkara D
Hum Gene Ther; 2018 Nov; 29(11):1235-1241. PubMed ID: 30132368
[TBL] [Abstract][Full Text] [Related]
60. Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.
Matsuzaki Y; Konno A; Mukai R; Honda F; Hirato M; Yoshimoto Y; Hirai H
Mol Neurobiol; 2017 Apr; 54(3):1745-1758. PubMed ID: 26884266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
